{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:29:02Z","timestamp":1791091742853,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.biopha.2013.07.001","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T22:19:10Z","timestamp":1373581150000},"page":"659-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Iatrogenic dry eye disease: An eledoisin\/carnitine and osmolyte drops study"],"prefix":"10.1016","volume":"67","author":[{"given":"Marcella","family":"Nebbioso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariasilvia","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloisa","family":"Librando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Maria","family":"Plateroti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pescosolido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2013.07.001_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop","volume":"5","author":"Lemp","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.biopha.2013.07.001_bib0010","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1167\/iovs.03-0270","article-title":"The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity","volume":"44","author":"Begley","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.biopha.2013.07.001_bib0015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0008-4182(04)80071-1","article-title":"Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sj\u00f6gren's syndrome","volume":"39","author":"Adatia","year":"2004","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1477-7525-2-44","article-title":"Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sj\u00f6gren's syndrome-related dry eye","volume":"2","author":"Vitale","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.biopha.2013.07.001_bib0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bjo.76.3.157","article-title":"The importance of the precorneal tear film for the quality of optical imaging","volume":"76","author":"Rieger","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0030","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0161-6420(99)00513-8","article-title":"Corneal surface irregularity and the effect of artificial tears in aqueous tear deficiency","volume":"106","author":"Liu","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2013.07.001_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9394(01)01365-4","article-title":"Impaired functional visual acuity of dry eye patients","volume":"133","author":"Goto","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0040","first-page":"250","article-title":"Tear osmolarity variation in the dry eye","volume":"84","author":"Farris","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.biopha.2013.07.001_bib0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004397-199403410-00005","article-title":"Human tear film electrolyte concentrations in health and dry eye disease","volume":"34","author":"Gilbard","year":"1994","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.biopha.2013.07.001_bib0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1542-0124(12)70028-9","article-title":"Tear osmolarity","volume":"4","author":"Murube","year":"2006","journal-title":"Ocul Surf"},{"key":"10.1016\/j.biopha.2013.07.001_bib0055","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1167\/iovs.05-1504","article-title":"Tear film osmolarity: determination of a referent for dry eye diagnosis","volume":"47","author":"Tomlinson","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.biopha.2013.07.001_bib0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","article-title":"Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj\u00f6gren's syndrome keratoconjunctivitis sicca","volume":"19","author":"Pflugfelder","year":"1999","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.biopha.2013.07.001_bib0065","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1350-9462(98)00004-4","article-title":"Tear dynamics and dry eye","volume":"17","author":"Tsubota","year":"1998","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.biopha.2013.07.001_bib0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archopht.1978.03910050373015","article-title":"Osmolarity of tear microvolumes in keratoconjunctivitis sicca","volume":"96","author":"Gilbard","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF02138250","article-title":"Structure and pharmacological actions of eledoisin, the active endecapeptide of the posterior salivary glands of Eledone","volume":"18","author":"Erspamer","year":"1962","journal-title":"Experientia"},{"key":"10.1016\/j.biopha.2013.07.001_bib0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1476-5381.1963.tb01488.x","article-title":"The action of eledoisin on the systemic arterial blood pressure of some experimental animals","volume":"20","author":"Erspamer","year":"1963","journal-title":"Br J Pharmacol Chemiother"},{"key":"10.1016\/j.biopha.2013.07.001_bib0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/01.RES.15.5.371","article-title":"Peripheral vasodilator action of eledoisin, bradykinin, and nitroglycerin in anesthetized dogs","volume":"15","author":"Bergamaschi","year":"1964","journal-title":"Circ Res"},{"key":"10.1016\/j.biopha.2013.07.001_bib0090","first-page":"1668","article-title":"Vasodilating action of eledoisin on the intact and denervated skeletal muscle preparation of the dog","volume":"16","author":"Bergamaschi","year":"1966","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.biopha.2013.07.001_bib0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000305824","article-title":"The treatment of Sj\u00f6gren syndrome with physalaemin","volume":"158","author":"De Caro","year":"1969","journal-title":"Opthalmologica"},{"key":"10.1016\/j.biopha.2013.07.001_bib0100","first-page":"507","article-title":"Tratamiento del syndrome de Goujerot-Sj\u00f6gren mediante la asociacion de fisalemin-eledoisina y medroxiprogesterona","volume":"33","author":"Jose","year":"1973","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0105","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/OPX.0b013e3182348c28","article-title":"Comparison of three lubrificant eye drop solutions in dry eye patients","volume":"88","author":"Evangelista","year":"2011","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.biopha.2013.07.001_bib0110","doi-asserted-by":"crossref","first-page":"E132","DOI":"10.1097\/OPX.0b013e318194e767","article-title":"L-carnitine and short chain ester in tears from patients with dry eye","volume":"86","author":"Pescosolido","year":"2009","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.biopha.2013.07.001_bib0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jfo.2010.06.018","article-title":"Preservatives in eye drops: towards awareness of their toxicity","volume":"33","author":"Vaede","year":"2010","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0120","doi-asserted-by":"crossref","first-page":"E928","DOI":"10.1097\/OPX.0b013e31821c6ca4","article-title":"Psychophysical and electrophysiological testing in ocular hypertension","volume":"88","author":"Nebbioso","year":"2011","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.biopha.2013.07.001_bib0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1442-9071.2003.00760.x","article-title":"Effects of topical antiglaucoma drugs on apoptosis rates of conjunctival epithelial cells in glaucoma patients","volume":"32","author":"Do\u011fan","year":"2004","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0181-5512(07)89584-2","article-title":"A new approach for better comprehension of diseases of the ocular surface","volume":"30","author":"Baudouin","year":"2007","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0135","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","article-title":"Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies","volume":"106","author":"Baudouin","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2013.07.001_bib0140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative-free glaucoma medication","volume":"86","author":"Pisella","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0145","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1517\/14656566.2012.705830","article-title":"Fixed topical combinations in glaucomatous patients and ocular discomfort","volume":"13","author":"Nebbioso","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.biopha.2013.07.001_bib0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ophtha.2007.01.036","article-title":"The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways","volume":"115","author":"Baudouin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2013.07.001_bib0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1076\/ceyr.27.4.253.16603","article-title":"In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system","volume":"27","author":"Blondin","year":"2003","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.biopha.2013.07.001_bib0160","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","article-title":"Corneal and conjunctival changes caused by commonly used glaucoma medications","volume":"23","author":"Noecker","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.biopha.2013.07.001_bib0165","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1167\/iovs.03-1067","article-title":"Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study","volume":"45","author":"Pisella","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.biopha.2013.07.001_bib0170","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajo.2008.10.019","article-title":"An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology","volume":"147","author":"Martone","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0175","first-page":"1806","article-title":"Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells","volume":"17","author":"Ammar","year":"2011","journal-title":"Mol Vis"},{"key":"10.1016\/j.biopha.2013.07.001_bib0180","first-page":"782","article-title":"Flow cytometric analysis of HLA-DR, IL-6 and IL-8 expression by conjunctival epithelial cells from patients with prolonged topical antiglaucoma treatments","volume":"26","author":"Bensoussan","year":"2003","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"10.1016\/j.biopha.2013.07.001_bib0185","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/01913123.2011.634090","article-title":"Trabecular meshwork in normal and pathological eyes","volume":"36","author":"Pescosolido","year":"2012","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0190","first-page":"503","article-title":"Un Nuevo trataimento medicamentoso de las manifestaciones oculars del syndrome de Sj\u00f6gren","volume":"33","author":"Luis Soto","year":"1973","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0195","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00503978","article-title":"Action of eledoisin on human lacrimal secretion in normal and pathological conditions","volume":"279","author":"Impicciatore","year":"1973","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2478\/v10007-008-0009-0","article-title":"Comparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbits","volume":"58","author":"El-Shazly","year":"2008","journal-title":"Acta Pharm"},{"key":"10.1016\/j.biopha.2013.07.001_bib0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/02713689009044523","article-title":"Eledoisin and lacrimal secretion in the rabbit","volume":"9","author":"Rossi","year":"1990","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.biopha.2013.07.001_bib0210","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF00203320","article-title":"Effect of eledoisin on tear volume and tear flow in humans as assessed by fluorophotometry","volume":"229","author":"G\u00f6bbels","year":"1991","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0215","first-page":"330","article-title":"A primary study of L-carnitine protective effect on corneal and conjunctival epithelium of mouse dry eye model induced by hyperosmolar saline","volume":"48","author":"Huo","year":"2012","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"10.1016\/j.biopha.2013.07.001_bib0220","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ajo.2010.11.003","article-title":"Amino Acid profiles in human tear fluids analyzed by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry","volume":"151","author":"Nakatsukasa","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.biopha.2013.07.001_bib0225","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5301\/ejo.5000117","article-title":"Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease","volume":"22","author":"Baudouin","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.biopha.2013.07.001_bib0230","first-page":"594","article-title":"Effect of physalaemine on lacrimal and salivary secretion in Sj\u00f6gren's syndrome","volume":"20","author":"Sala","year":"1968","journal-title":"Reumatismo"},{"key":"10.1016\/j.biopha.2013.07.001_bib0235","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/02713688908995762","article-title":"Signal trasduction and control of lacrimal gland protein secretion: a review","volume":"8","author":"Dartt","year":"1971","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.biopha.2013.07.001_bib0240","first-page":"1666","article-title":"Neuro-peptides and the innervations of the avian lacrimal gland","volume":"30","author":"Walcott","year":"1989","journal-title":"Invest Opthalmol Vis Sci"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332213000899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332213000899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:52:00Z","timestamp":1760093520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332213000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0753332213000899"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2013.07.001","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iatrogenic dry eye disease: An eledoisin\/carnitine and osmolyte drops study","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2013.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}